168 related articles for article (PubMed ID: 38467144)
1. Direct Oral Anticoagulants for Pulmonary Embolism.
Pizzi R; Cimini LA; Ageno W; Becattini C
Hamostaseologie; 2024 Jun; 44(3):206-217. PubMed ID: 38467144
[TBL] [Abstract][Full Text] [Related]
2. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
Forster R; Stewart M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
[TBL] [Abstract][Full Text] [Related]
5. Direct oral anticoagulants for the treatment of pulmonary embolism in patients with renal impairment.
Rivera-Lebron B; Bauersachs R
Thromb Res; 2021 Aug; 204():101-107. PubMed ID: 34167039
[TBL] [Abstract][Full Text] [Related]
6. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421
[TBL] [Abstract][Full Text] [Related]
7. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.
Li M; Li J; Wang X; Hui X; Wang Q; Xie S; Yan P; Tian J; Li J; Xie P; Yang K; Yao L
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010957. PubMed ID: 37057837
[TBL] [Abstract][Full Text] [Related]
8. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
Haas S; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Zaghdoun A; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
J Thromb Haemost; 2019 Oct; 17(10):1694-1706. PubMed ID: 31220403
[TBL] [Abstract][Full Text] [Related]
10. Using direct oral anticoagulants (DOACs) in cancer and other high-risk populations.
van Es N; Büller HR
Hematology Am Soc Hematol Educ Program; 2015; 2015():125-31. PubMed ID: 26637711
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism.
Coons JC; Albert L; Bejjani A; Iasella CJ
Pharmacotherapy; 2020 Mar; 40(3):204-210. PubMed ID: 31968126
[TBL] [Abstract][Full Text] [Related]
12. Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registry.
Chopard R; Andarelli JN; Humbert S; Falvo N; Morel-Aleton M; Bonnet B; Napporn G; Kalbacher E; Obert L; Degano B; Cappelier G; Cottin Y; Schiele F; Meneveau N
Thromb Res; 2019 Feb; 174():27-33. PubMed ID: 30553162
[TBL] [Abstract][Full Text] [Related]
13. Operative spinal trauma: Thromboprophylaxis with low molecular weight heparin or a direct oral anticoagulant.
Hamidi M; Zeeshan M; Kulvatunyou N; Mitra HS; Hanna K; Tang A; Northcutt A; O'Keeffe T; Joseph B
J Thromb Haemost; 2019 Jun; 17(6):925-933. PubMed ID: 30924300
[TBL] [Abstract][Full Text] [Related]
14. Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy.
Finks SW; Trujillo TC; Dobesh PP
Ann Pharmacother; 2016 Jun; 50(6):486-501. PubMed ID: 26917821
[TBL] [Abstract][Full Text] [Related]
15. Treatment Patterns and Clinical Outcomes in Korean Cancer Patients With Venous Thromboembolism: A Retrospective Cohort Study.
Bang SM; Kang JH; Hong MH; Ahn JS; Oh SY; Baek JH; Choi YJ; Shin SH; Kim YJ; Gil HY; Park HE; Lee J; Park EL
Clin Appl Thromb Hemost; 2021; 27():1076029620979575. PubMed ID: 33471574
[TBL] [Abstract][Full Text] [Related]
16. Direct oral anticoagulants in the treatment of pulmonary embolism.
Eldredge JB; Spyropoulos AC
Curr Med Res Opin; 2018 Jan; 34(1):131-140. PubMed ID: 28771049
[TBL] [Abstract][Full Text] [Related]
17. Management of cancer-associated venous thromboembolism - a case-based practical approach.
Voigtlaender M; Langer F
Vasa; 2018 Feb; 47(2):77-89. PubMed ID: 29325495
[TBL] [Abstract][Full Text] [Related]
18. Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism.
Robertson L; Kesteven P; McCaslin JE
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD010957. PubMed ID: 26636644
[TBL] [Abstract][Full Text] [Related]
19. Early, real-world experience with direct oral anticoagulants in the treatment of intermediate-high risk acute pulmonary embolism.
Santos SM; Cunha S; Baptista R; Monteiro S; Monteiro P; Gonçalves F; Pêgo M
Rev Port Cardiol; 2017 Nov; 36(11):801-806. PubMed ID: 29126891
[TBL] [Abstract][Full Text] [Related]
20. Outpatient Treatment of Low-risk Pulmonary Embolism in the Era of Direct Oral Anticoagulants: A Systematic Review.
Maughan BC; Frueh L; McDonagh MS; Casciere B; Kline JA
Acad Emerg Med; 2021 Feb; 28(2):226-239. PubMed ID: 32779290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]